Highlights
- •Sociodemographic characteristics of patients with multiple sclerosis in morocco.
- •The majority of patients with multiple sclerosis have no healthcare coverage.
- •Most of the patients surveyed did not have access to disease-modifying treatment.
- •Diagnosis and access to treatment are closely linked to certain sociodemographic factors.
- •In Morocco, the diagnosis of multiple sclerosis is delayed.
Abstract
Objective
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Multiple Sclerosis and Related DisordersReferences
- Diagnostic delay of multiple sclerosis in a Portuguese population.Acta Med. Port. 2019; 32: 289-294https://doi.org/10.20344/amp.11187
- How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.Mult. Scler. 2020; 26: 489-500https://doi.org/10.1177/1352458518823955
- [Social and economic impact of multiple sclerosis].Rev. Prat. 1999; 49: 1890-1893
- Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients.Mult. Scler. Relat. Disord. 2020; 40101930https://doi.org/10.1016/j.msard.2020.101930
- Impact socioprofessionnel précoce de la sclérose en plaques : une étude prospective d'une série de 24 patients.Archives des Maladies Professionnelles et de l'Environnement. 2016; 77: 165-178https://doi.org/10.1016/j.admp.2015.09.004
- Delayed diagnosis of multiple sclerosis in a low prevalence country.Neurolog. Res. 2021; 43: 521-527https://doi.org/10.1080/01616412.2020.1866374
Charil, A., Yousry, T.A., Rovaris, M., Barkhof, F., Stefano, N.D., Fazekas, F., Miller, D.H., Montalban, X., Simon, J.H., Polman, C., & Filippi, M. (2006). MRI and the diagnosis of multiple sclerosis : Expanding the concept of “no better explanation”. 12.
- Statut professionnel au cours de la sclérose en plaques.Rev. Neurol. (Paris). 2018; 174: S103https://doi.org/10.1016/j.neurol.2018.01.233
- Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study).J. Neurol. 2010; 257: 1500-1507https://doi.org/10.1007/s00415-010-5560-1
Flemmen, H. (2019). Socioeconomic factors as predictors for ms susceptibility and disease progression—Validation of a new norwegian questionnaire. https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/279125/.
- The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort.Mult. Scler. Relat. Disord. 2022; 61https://doi.org/10.1016/j.msard.2022.103759
- The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.BMC Health Services Res. 2021; 21 (Article): 1https://doi.org/10.1186/s12913-021-06251-4
- Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990-2016.Acta Neurologica. Belgica. 2021; 121: 199-204https://doi.org/10.1007/s13760-020-01528-7
- Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990-2016.Acta Neurologica.. Belgica. 2021; 121: 199-204https://doi.org/10.1007/s13760-020-01528-7
- Socioeconomic status and disability progression in multiple sclerosis : a multinational study.Neurology. 2019; 92: e1497-e1506https://doi.org/10.1212/WNL.0000000000007190
HCP. (2021a). Note d'information du Haut-Commissariat au Plan relative aux principales caractéristiques de la population active occupée en 2021 (p. 7). Haut commissariat au plan. https://www.hcp.ma/Note-D-information-du-haut-commissariat-au-plan-relative-aux-principales-caracteristiques-de-la-population-active_a2825.html.
HCP. (2021b). Note d'information du Haut-Commissariat au Plan relative aux principales caractéristiques de la population active occupée en 2021 (p. 7). Haut commissariat au plan. https://www.hcp.ma/Note-D-information-du-haut-commissariat-au-plan-relative-aux-principales-caracteristiques-de-la-population-active_a2825.html.
- Inflammatory Changes and Apoptosis in Parkinson's Disease.(Éds)in: Mizuno Y. Fisher A. Hanin I. Mapping the Progress of Alzheimer's and Parkinson's Disease. Springer, US2002: 259-263https://doi.org/10.1007/978-0-306-47593-1_43
- Employment in individuals with multiple sclerosis.Int. J. Rehabil. Res.. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation. 1986; 9 (Article): 2https://doi.org/10.1097/00004356-198606000-00006
Lassmann, H. (2018). Multiple Sclerosis Pathology. Cold Spring Harbor Laboratory Press.
- Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online.Mult. Scler. Related Disor. 2019; 27: 239-246https://doi.org/10.1016/j.msard.2018.10.113
- Trends in health inequalities in 27 European countries.Proc. National Acad. Sci. 2018; 115: 6440-6445https://doi.org/10.1073/pnas.1800028115
- Diagnosis and treatment of multiple sclerosis : a review.JAMA. 2021; 325: 765-779https://doi.org/10.1001/jama.2020.26858
- Access to and utilization of neurologists by people with multiple sclerosis.Neurology. 2008; 70: 1141-1149https://doi.org/10.1212/01.wnl.0000306411.46934.ef
- Access to and utilization of neurologists by people with multiple sclerosis.Neurology. 2008; 70: 1141-1149https://doi.org/10.1212/01.wnl.0000306411.46934.ef
- Multiple sclerosis diagnosis delay and its associated factors among Iranian patients.Clin. Neurol. Neurosurg. 2020; 199106278https://doi.org/10.1016/j.clineuro.2020.106278
Morocan ministry of health. (2019a). Health in figures 2019 (p. 121). Morocan ministry of health. https://www.sante.gov.ma/Documents/2021/12/Sante%20en%20chiffres%202019%20.pdf.
Morocan ministry of health. (2019b). Health in figures 2019 (p. 121). Morocan ministry of health. https://www.sante.gov.ma/Documents/2021/12/Sante%20en%20chiffres%202019%20.pdf.
Multiple Sclerosis International Federation. (2020). Clinical Management of Multiple Sclerosis Around the world, Key Finding About the Diagnosis and Clinical Management of MS (3rd Edition; p. 45).
Multiple Sclerosis International Federation. (2021). MS Treatments and Therapies. MS International Federation. https://www.msif.org/living-with-ms/treatments/?lang=en/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/feed/.
Multiple Sclerosis International Federation, Atlas of MS. (2020a). Mapping multiple sclerosis around the world key epidemiology findings (3rd Edition). https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf.
Multiple Sclerosis International Federation, Atlas of MS. (2020b). Morocco—Atlas of MS. https://www.atlasofms.org/fact-sheet/morocco.
Multiple Sclerosis Society. (2019). Disease modifying therapies booklet. https://www.mssociety.org.uk/care-and-support/resources-and-publications/publications-search/disease-modifying-therapies-booklet.
OECD. (2022). Employment rate (indicator). https://doi.org/OECD (2022), Employment Rate . doi: 10.1787/1de68a9b-en10.1787/1de68a9b-en (Accessed on 30 July 2022).
- Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis.Mul. Scler. Related Disor. 2021; 48102720https://doi.org/10.1016/j.msard.2020.102720
- Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis.Mul. Scler. Related Disor. 2021; 48102720https://doi.org/10.1016/j.msard.2020.102720
- Multiaxial polarity determines individual cellular and nuclear chirality.Cellul. Molecular Bioengin. 2017; 10: 63-74https://doi.org/10.1007/s12195-016-0467-2
- Multiple sclerosis and employment barriers : a systemic perspective on diagnosis and intervention.Work. 2003; 21: 17-23
- The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis : mixed-Methods Study.J. Med. Internet Res. 2018; 20: e11168https://doi.org/10.2196/11168
- Access to care for multiple sclerosis in times of economic crisis in greece—The hope II study.Int. J. Health Policy Manag. 2015; 5https://doi.org/10.15171/ijhpm.2015.173
- Access to care for multiple sclerosis in times of economic crisis in Greece—The HOPE II study.Int. J. Health Policy Manag. 2015; 5 (Article): 2https://doi.org/10.15171/ijhpm.2015.173
- Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases.Mult. Scler. Related Disor. 2019; 32: 97-102https://doi.org/10.1016/j.msard.2019.04.012
World Health Organization. (2017). Human rights and health. https://www.who.int/news-room/fact-sheets/detail/human-rights-and-health.
- Consensus recommendations for the diagnosis and treatment of multiple sclerosis : 2019 revisions to the MENACTRIMS guidelines.Mult. Scler. Related Disor. 2020; 37101459https://doi.org/10.1016/j.msard.2019.101459
